Patent details

Basic Information

Publication number:

EP3180331

PCT Application Number:

US2015045395

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP157540998

PCT Publication Number:

WO2016025904

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

POLYMORPHS OF SELINEXOR

French Title of Invention:

POLYMORPHES DU SELINEXOR

German Title of Invention:

POLYMORPHE VON SELINEXOR

SPC Number:

Dates

Filing date:

14/08/2015

Grant date:

08/06/2022

EP Publication Date:

21/06/2017

PCT Publication Date:

18/02/2016

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

08/06/2022

EP B1 Publication Date:

08/06/2022

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

14/08/2022

Expiration date:

14/08/2035

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

01/06/2022

 

 

Name:

Karyopharm Therapeutics Inc.

Address:

85 Wells Avenue, Newton, MA 02459, United States (US)

Inventor

1

Name:

AUSTAD, Brian Clinton

Address:

United States (US)

2

Name:

ROE, David G.

Address:

Canada (CA)

Priority

Priority Number:

201462038069 P

Priority Date:

15/08/2014

Priority Country:

United States (US)

Classification

IPC classification:

C07D 403/12; A61K 31/497; A61P 35/00; A61P 25/00; A61P 31/00;

Publication

European Patent Bulletin

1

Issue number:

202223

Publication date:

08/06/2022

Description:

Grant (B1)

2

Issue number:

202228

Publication date:

13/07/2022

Description:

Application number/publication number of the divisional application (Art. 76) changed

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages